TECHNOLOGICAL ADVANCES IN THE DIAGNOSIS AND MONITORING OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): CHALLENGES AND PERSPECTIVES IN THE CONTEXT OF PUBLIC HEALTH IN BRAZIL
Abstract
This study aims to analyze technological advances in the diagnosis and monitoring of chronic lymphocytic leukemia (CLL), highlighting its relevance in the context of public health. This is a qualitative and descriptive literature review, based on searches in recognized scientific databases, with the selection of studies published between 2020 and 2026. Specific descriptors combined by Boolean operators were used, allowing the identification of relevant scientific productions on the subject. The results show that techniques such as flow cytometry, molecular analysis, and the use of artificial intelligence have contributed significantly to greater diagnostic accuracy and monitoring of the disease. In addition, it has been observed that these advances allow for better risk stratification and more effective clinical follow-up. It is concluded that the incorporation of these technologies represents an important advance for biomedical practice, favoring early detection, appropriate treatment and improvement of patients' quality of life.
Author Biographies
Undergraduate student in Biomedicine at Centro Universitário Fametro. Postgraduate student in Clinical Hematology and Hemotherapy.
Undergraduate student in Biomedicine at Centro Universitário Fametro, with interest in the field of biotechnology and scientific research.
Undergraduate student in Biomedicine at Centro Universitário Fametro. Interested in the fields of clinical analysis and hematology.
References
BARBOSA, Renata M.; et al. Monitoramento clínico e laboratorial da leucemia linfocítica crônica. Revista Panamericana de Salud Pública, Washington, v. 47, p. 1-9, 2023. Disponível em: https://iris.paho.org/handle/10665.2/56390 Acesso em: 15/02/2026.
DIDEHBAN, S.; et al. Evaluation of peripheral blood smear, bone marrow aspiration and flow cytometry in CLL diagnosis. Journal of Hematology, London, v. 15, n. 1, p. 33-41, 2024. Disponível em: https://pmc.ncbi.nlm.nih.gov/articles/PMC11304456/ Acesso em: 15/02/2026.
ELHADARY, Mohamed; et al. Revolutionizing chronic lymphocytic leukemia diagnosis: emerging technologies. Leukemia Research, Amsterdam, v. 132, p. 106890, 2023. Disponível em: https://www.sciencedirect.com/science/article/pii/S0268960X23000954 Acesso em: 15/02/2026.
FERREIRA, Gabriela R.; et al. Biomarcadores moleculares no diagnóstico precoce de leucemias. Revista Foco, Curitiba, v. 18, n. 2, p. 1-10, 2025. Disponível em: https://ojs.focopublicacoes.com.br/foco/article/view/10178 Acesso em: 15/02/2026.
GEHLOT, Shiv; et al. SDCT-AuxNet: deep learning architecture for leukemia diagnosis. arXiv Preprint, Ithaca, 2020. Disponível em: https://arxiv.org/abs/2006.00304 Acesso em: 15/02/2026.
HALLEK, Michael. Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment. American Journal of Hematology, Hoboken, v. 95, n. 7, p. 844-861, jul. 2020. Disponível em: https://pubmed.ncbi.nlm.nih.gov/31364186/ Acesso em: 15/02/2026.
HALLEK, Michael. Chronic lymphocytic leukemia: 2025 update on pathogenesis, diagnosis and treatment. American Journal of Hematology, Hoboken, v. 100, n. 1, p. 1-15, 2025. Disponível em: https://pubmed.ncbi.nlm.nih.gov/39871707/ Acesso em: 15/02/2026.
HAQ, Hira; et al. Prognostic markers in chronic lymphocytic leukemia. Journal of Hematology, London, v. 11, n. 2, p. 101-110, 2020. Disponível em: https://pmc.ncbi.nlm.nih.gov/articles/PMC7150385/ Acesso em: 15/02/2026.
HOXHA, O.; et al. Investigation of early-stage chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis. Journal of Clinical Pathology, London, v. 78, n. 2, p. 120-128, 2025. Disponível em: https://pubmed.ncbi.nlm.nih.gov/40484975/ Acesso em: 15/02/2026.
INSTITUTO NACIONAL DE CÂNCER. Leucemia linfocítica crônica: diagnóstico e tratamento. Rio de Janeiro: INCA, 2022. Disponível em: https://www.inca.gov.br/tipos-de-cancer/leucemia Acesso em: 15/02/2026.
KANG, Akum S.; et al. Machine learning approaches to automated flow cytometry diagnosis of chronic lymphocytic leukemia. arXiv Preprint, Ithaca, 2021. Disponível em: https://arxiv.org/abs/2107.09728 Acesso em: 15/02/2026.
LI, W.; et al. Flow cytometry in the diagnosis of leukemias. StatPearls Publishing, Treasure Island, 2022. Disponível em: https://www.ncbi.nlm.nih.gov/books/NBK586209/ Acesso em: 15/02/2026.
LIM, Y. J.; et al. Re-emergence of circulating non-malignant B cells in chronic lymphocytic leukemia.
Scientific Reports, London, v. 15, 2025. Disponível em: https://www.nature.com/articles/s41598-025-16558-5 Acesso em: 15/02/2026.
NATIONAL CANCER INSTITUTE. Chronic lymphocytic leukemia treatment (PDQ). Bethesda, 2023. Disponível em: https://www.cancer.gov/types/leukemia/patient/cll-treatment-pdq Acesso em: 15/02/2026.
NIYONIZEYE, E.; et al. Building a new score system for the diagnosis of chronic lymphocytic leukemia. Cancers, Basel, v. 17, n. 3, p. 415-428, 2025. Disponível em: https://pmc.ncbi.nlm.nih.gov/articles/PMC12031950/ Acesso em: 15/02/2026.
OZDEMIR, Z. N.; et al. A novel differential diagnosis algorithm for chronic lymphocytic leukemia using flow cytometry. Hematology, Transfusion and Cell Therapy, Rio de Janeiro, v. 45, n. 3, p. 257-265, 2023. Disponível em: https://www.scielo.br/j/htct/a/DbvLCvMQddn5493HThz5zbK/ Acesso em: 15/02/2026.
PONTES, Ana Paula; et al. A importância da imunofenotipagem por citometria de fluxo no diagnóstico das leucemias. Revista de Ciências da Saúde Nova Esperança, João Pessoa, v. 22, n. 2, p. 197-204, 2024. Disponível em: https://revista.facene.com.br/index.php/revistane/article/download/946/655/5443 Acesso em: 15/02/2026.
SALEM, Daniel A.; et al. Clinical flow-cytometric testing in chronic lymphocytic leukemia. Clinical Cytometry, Hoboken, v. 96, n. 5, p. 365-372, 2020. Disponível em: https://pmc.ncbi.nlm.nih.gov/articles/PMC8276061/ Acesso em: 15/02/2026.
SATHITAKORN, O.; et al. Optimizing markers for chronic lymphocytic leukemia diagnosis using flow cytometry. Journal of Clinical Laboratory Analysis, Hoboken, v. 39, n. 1, 2025. Disponível em: https://onlinelibrary.wiley.com/doi/full/10.1002/jcla.70116 Acesso em: 15/02/2026.
SEHEULT, J. N.; et al. Clinical validation of automated flow cytometry analysis for minimal residual disease in CLL. Cancers, Basel, v. 17, n. 10, p. 1688-1701, 2025. Disponível em: https://www.mdpi.com/2072-6694/17/10/1688 Acesso em: 15/02/2026.
SILVA, M. A.; et al. Desafios na abordagem da leucemia linfocítica crônica. Revista Científica da Faculdade de Medicina de Campos, Campos, v. 19, n. 2, p. 1-12, 2024. Disponível em: https://revista.fmc.br/ojs/index.php/RCFMC/article/download/810/432/5108 Acesso em: 15/02/2026.
SILVA, T. B. M.; et al. Uso da citometria de fluxo no diagnóstico de leucemias. Journal of Hematology Research, Amsterdam, v. 14, n. 2, p. 45-60, 2025. Disponível em: https://www.sciencedirect.com/science/article/pii/S2531137925006108 Acesso em: 15/02/2026.
VENUGOPALAN, R. K.; et al. Leukemia-associated aberrant immunophenotype: a flow cytometry study. Journal of Hematopathology, London, v. 16, n. 4, p. 215-223, 2023. Disponível em: https://pubmed.ncbi.nlm.nih.gov/37787304/ Acesso em: 15/02/2026.
WAINMAN, L. M. Chronic lymphocytic leukemia: current knowledge and diagnostic approaches. StatPearls Publishing, Treasure Island, 2023. Disponível em: https://www.ncbi.nlm.nih.gov/books/NBK594958/ Acesso em: 15/02/2026.
WANG, W. J.; et al. Immunophenotypic, cytogenetic and mutational features of atypical chronic lymphocytic leukemia. Leukemia Research, Amsterdam, v. 134, p. 107-115, 2025. Disponível em: https://pubmed.ncbi.nlm.nih.gov/40814768/ Acesso em: 15/02/2026.
WÖDLINGER, Matthias; et al. Automated identification of cell populations in flow cytometry data with transformers. arXiv Preprint, Ithaca, 2021. Disponível em: https://arxiv.org/abs/2108.10072 Acesso em: 15/02/2026.
WORLD HEALTH ORGANIZATION. WHO classification of haematolymphoid tumours. 5. ed. Lyon: WHO Press, 2022. Disponível em: https://publications.iarc.fr/Book-And-Report-Series/Who-Classification-Of-Tumours Acesso em: 15/02/2026.
License
Copyright (c) 2026 RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218
This work is licensed under a Creative Commons Attribution 4.0 International License.
Os direitos autorais dos artigos/resenhas/TCCs publicados pertecem à revista RECIMA21, e seguem o padrão Creative Commons (CC BY 4.0), permitindo a cópia ou reprodução, desde que cite a fonte e respeite os direitos dos autores e contenham menção aos mesmos nos créditos. Toda e qualquer obra publicada na revista, seu conteúdo é de responsabilidade dos autores, cabendo a RECIMA21 apenas ser o veículo de divulgação, seguindo os padrões nacionais e internacionais de publicação.